Brief: GRAIL Says FDA Advisory Committee To Review GRAIL Galleri PMA Application On September 23
07/08/2026 16:24
BRIEF-GRAIL Says FDA Advisory Committee To Review GRAIL Galleri PMA Application On September 23 Aug 7 (Reuters) - GRAIL Inc GRAL.O:
GRAIL ANNOUNCES FDA ADVISORY COMMITTEE MEETING TO REVIEW PREMARKET APPROVAL APPLICATION FOR THE GALLERI® MULTI-CANCER EARLY DETECTION TEST
GRAIL - FDA ADVISORY COMMITTEE TO REVIEW GRAIL GALLERI PMA APPLICATION ON SEPT. 23, 2026
Source text: ID:nPn7vHCzQa
Further company coverage: GRAL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grail
See all newsGrail rises as TD Cowen more than doubles PT on FDA, Medicare optimism
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
U.S. RESEARCH ROUNDUP-Chevron, Mobility Global, Tesla
Street View: Grail cancer test's progress boosts prospects for multi-cancer detection market
NASDAQ RESUMED AT 07:05 AM